21 DEC 2015 Nutraceuticals Otsuka Pharmaceutical Concludes Cooperative Agreement to Maintain and Promote Healthy Lifestyles with Shiga Prefecture
7 DEC 2015 Pharmaceuticals Otsuka Files for Approval in Japan for an Additional Indication for the Antipsychotic ABILIFY: Excitability Associated with Juvenile Autism
4 DEC 2015 Nutraceuticals Otsuka Pharmaceutical Concludes Comprehensive Agreement for Community Health Initiatives with Fukuoka Prefecture
26 NOV 2015 Pharmaceuticals E Keppra® Injectable, to be Launched in Japan on December 1; Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged 4 and Over with Partial-onset Seizures
17 NOV 2015 Pharmaceuticals Otsuka Pharmaceutical Affiliate Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients with Alzheimer's Disease
16 NOV 2015 Nutraceuticals Nature Made Ginkgo Biloba Otsuka Pharmaceutical Introduces Japan's First Food with Specific Function Claim for Cognitive Functions
16 NOV 2015 Corporate 10,000 Attend 7th Asan Walking Festival in Itano on November 15 Cosponsored by Otsuka Pharmaceutical Tokushima Itano Factory
7 OCT 2015 Nutraceuticals Acquisition of BIOCENTURY, Leading Spanish Health and Functional Food Company
1 OCT 2015 Nutraceuticals Otsuka Pharmaceutical Named "Best Communicator" 'Heatstroke Prevention Communication Project' Hitosuzumi Awards 2015
1 OCT 2015 Pharmaceuticals New Drug Application for Carteolol Hydrochloride/ Latanoprost, a Novel Combined Ophthalmic Solution, Submitted in Japan for the Treatment of Glaucoma and Ocular Hypertension
11 SEP 2015 Pharmaceuticals U.S. FDA Accepts First Digital Medicine New Drug Application for Otsuka and Proteus Digital Health
3 SEP 2015 Nutraceuticals Three New SOYJOY Bars, Enhanced with More Fruit, More Flavor Raisin, Apple and Hawthorn Berry
27 AUG 2015 Nutraceuticals Three Nature Made Products Receive Foods with Function Claims Labels specify benefits for eyes and inhibition of triglyceride levels in the blood
27 AUG 2015 Nutraceuticals Omugi Gohan Barley Rice from OMUGI SEIKATSU Receive Food with Function Claims Labels specify three benefits, including control of glucose absorption
13 AUG 2015 Pharmaceuticals Otsuka Pharmaceutical's Subsidiary Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026 in the U.S.
6 AUG 2015 Nutraceuticals New Pen-type UL·OS Medicated Skin Whitening Helps Men Avoid Dark Spots and Freckles by Inhibiting Melanin Formation
29 JUL 2015 Pharmaceuticals Otsuka Pharmaceutical's Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of Cambridge
16 JUL 2015 Pharmaceuticals Efficacy Results of Otsuka's Delamanid (Deltyba™) for Extensively Drug-Resistant Tuberculosis (XDR-TB) Published in the New England Journal of Medicine
13 JUL 2015 Pharmaceuticals U.S. FDA Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia
1 JUL 2015 Nutraceuticals Otsuka Pharmaceutical Continues the Overseas Distribution Expansion of POCARI SWEAT East Timor Market Official Launch July 1, 2015
24 JUN 2015 Nutraceuticals Otsuka Pharmaceutical Enters Into Health Promotion Partnership Agreement with Saitama Prefecture
23 JUN 2015 Nutraceuticals Renovation of POCARI SWEAT Factory at Tianjin Otsuka Beverage Co., Ltd. Visitor-friendly Factory Conveys the Importance of Ions and Fluid Replenishment
28 MAY 2015 Pharmaceuticals Otsuka's JINARC® the First-Ever Treatment Approved in Europe for Adults Living with ADPKD, a Chronic Genetic Kidney Disease
20 MAY 2015 Nutraceuticals Overseas Distribution of ORONAMIN C DRINK Expands to Hong Kong Otsuka Pharmaceutical to Launch Carbonated Nutritional Beverage in Rapidly Growing Hong Kong Market
20 MAY 2015 Pharmaceuticals New Treatment Option in Japan for People Living With Schizophrenia - Abilify for Extended-release Injectable Suspension, for Intramuscular Use, Launched on May 25
20 APR 2015 Pharmaceuticals Results of Phase III Study of Brexpiprazole in Adult Patients with Schizophrenia Published in American Journal of Psychiatry
7 APR 2015 Nutraceuticals Review of research on use by menopausal women of nutritional supplement equol appears in US women's health publication
1 APR 2015 Pharmaceuticals A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML) Otsuka's Major BCR-ABL mRNA Measurement Kit Covered by Health Insurance in Japan as of April 1
30 MAR 2015 Pharmaceuticals Pre-Filled Dual Chamber Syringe for Abilify Maintena® (Aripiprazole) Prolonged-Release Suspension for Injection, Used in the Treatment of Schizophrenia, Received Positive CHMP Opinion (Approval in EU)
26 MAR 2015 Pharmaceuticals Otsuka Granted Approval in Japan for a New Formulation of ABIILIFY - ABILIFY for Extended-release Injectable Suspension, for Intramuscular Use - Indicated for Schizophrenia
26 MAR 2015 Pharmaceuticals Novel Anti-epileptic Drug E Keppra® Filed in Japan for Additional Indication of Adjunctive Therapy for Generalized Tonic-clonic Seizures
26 MAR 2015 Pharmaceuticals New Drug Application for a Single Pack Containing TAKECAB for Eradication of Helicobacter pylori in Japan
19 MAR 2015 Pharmaceuticals The Union and Otsuka Open Nominations for 2nd Global TB Research & Innovation Award
10 MAR 2015 Nutraceuticals New SOYJOY With More Fruit! Renewed Strawberry and Blueberry Versions Contain More Fruit
6 MAR 2015 Corporate Otsuka Pharmaceutical Co., Ltd. Appoints Board Members and Statutory Auditors (PDF: 41.2 KB)
2 MAR 2015 Nutraceuticals Otsuka Pharmaceutical, Otsuka Wellness Vending and Asahi Soft Drinks Form Business Partnership for Vending Machine Sales
2 MAR 2015 Pharmaceuticals Otsuka and Bristol-Myers Squibb Announce a Change in Contract Regarding Collaboration in Japan in the Oncology Therapy Area
27 FEB 2015 Pharmaceuticals CHMP Recommends JINARC® (Tolvaptan) for Approval in EU: The First Pharmaceutical Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
27 FEB 2015 Pharmaceuticals First-ever treatment approved in Canada for adults living with ADPKD, a life-threatening kidney disease
27 FEB 2015 Corporate Otsuka Pharmaceutical Receives Princess Chichibu Memorial Award for Distinguished Service to Tuberculosis Elimination
26 FEB 2015 Pharmaceuticals TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan
20 FEB 2015 Pharmaceuticals Novel Anti-epileptic Drug E Keppra® Approved in Japan for Additional Indication as Monotherapy for Partial-onset Seizures, in Addition to Existing Indication as Adjunctive Therapy for These Seizures
18 FEB 2015 Nutraceuticals Supporting Tokyo Marathon Runners with Beverages and Nutrition Before, During, and After the Race
12 FEB 2015 Corporate Notice of Change of Representative Director (Concurrent Obituary) (PDF: 128.1 KB)
2 FEB 2015 Nutraceuticals Otsuka Pharmaceutical Expands Overseas Distribution of ORONAMIN C DRINK Carbonated nutritional beverage to be produced and sold in South Korea
8 JAN 2015 Pharmaceuticals Terminations of Otsuka's Contract With OncoTherapy Science, Inc. on a Candidate Therapeutic Vaccine for Pancreatic Cancer and Otsuka's Sublicensing Contract With Fuso Pharmaceutical Industries for the Marketing of a Candidate Therapeutic Vaccine, OTS102